4
Changes in Ownership
Eton Pharmaceuticals, Inc. Filed Acc 0001437749-25-037745
Chief Business Officer gave up 6,264 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krempa David Chief Business Officer | 2025-12-12 | Shares withheld for taxes | −6,264 | $17.00 | $106,488 | 632,180 | D |
| Derivatives | |||||||
| Krempa David Chief Business Officer | 2025-12-11 | Grant or award · Restricted Stock Units | +5,300 | 638,468 | D | ||
Loading xslF345X05/rdgdoc.xml…